• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床心血管磁共振物理:第二部分。

Cardiovascular magnetic resonance physics for clinicians: Part II.

机构信息

University of Leeds and Department of Medical Physics and Engineering, Leeds Teaching Hospitals NHS Trust, 1st Floor, Bexley Wing, St James's University Hospital, Leeds, LS9 7TF, UK.

出版信息

J Cardiovasc Magn Reson. 2012 Sep 20;14(1):66. doi: 10.1186/1532-429X-14-66.

DOI:10.1186/1532-429X-14-66
PMID:22995744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3533879/
Abstract

This is the second of two reviews that is intended to cover the essential aspects of cardiovascular magnetic resonance (CMR) physics in a way that is understandable and relevant to clinicians using CMR in their daily practice. Starting with the basic pulse sequences and contrast mechanisms described in part I, it briefly discusses further approaches to accelerate image acquisition. It then continues by showing in detail how the contrast behaviour of black blood fast spin echo and bright blood cine gradient echo techniques can be modified by adding rf preparation pulses to derive a number of more specialised pulse sequences. The simplest examples described include T2-weighted oedema imaging, fat suppression and myocardial tagging cine pulse sequences. Two further important derivatives of the gradient echo pulse sequence, obtained by adding preparation pulses, are used in combination with the administration of a gadolinium-based contrast agent for myocardial perfusion imaging and the assessment of myocardial tissue viability using a late gadolinium enhancement (LGE) technique. These two imaging techniques are discussed in more detail, outlining the basic principles of each pulse sequence, the practical steps required to achieve the best results in a clinical setting and, in the case of perfusion, explaining some of the factors that influence current approaches to perfusion image analysis. The key principles of contrast-enhanced magnetic resonance angiography (CE-MRA) are also explained in detail, especially focusing on timing of the acquisition following contrast agent bolus administration, and current approaches to achieving time resolved MRA. Alternative MRA techniques that do not require the use of an endogenous contrast agent are summarised, and the specialised pulse sequence used to image the coronary arteries, using respiratory navigator gating, is described in detail. The article concludes by explaining the principle behind phase contrast imaging techniques which create images that represent the phase of the MR signal rather than the magnitude. It is shown how this principle can be used to generate velocity maps by designing gradient waveforms that give rise to a relative phase change that is proportional to velocity. Choice of velocity encoding range and key pitfalls in the use of this technique are discussed.

摘要

这是两篇综述中的第二篇,旨在以一种易于理解且与临床医生在日常实践中使用 CMR 相关的方式,涵盖心血管磁共振(CMR)物理学的基本方面。从第一部分中描述的基本脉冲序列和对比机制开始,它简要讨论了进一步加速图像采集的方法。然后,它继续详细展示如何通过向快速自旋回波和亮血电影梯度回波技术添加射频准备脉冲来修改黑血对比行为,以衍生出许多更专业的脉冲序列。描述的最简单示例包括 T2 加权水肿成像、脂肪抑制和心肌标记电影脉冲序列。梯度回波脉冲序列的另外两个重要衍生,通过添加准备脉冲获得,与钆基造影剂的给药结合使用,用于心肌灌注成像和使用晚期钆增强(LGE)技术评估心肌组织活力。更详细地讨论了这两种成像技术,概述了每个脉冲序列的基本原理、在临床环境中获得最佳结果所需的实际步骤,以及在灌注的情况下,解释了影响灌注图像分析当前方法的一些因素。还详细解释了对比增强磁共振血管造影(CE-MRA)的关键原理,特别是重点介绍了在对比剂团注给药后采集的时间,以及实现时间分辨 MRA 的当前方法。概述了不需要使用内源性对比剂的替代 MRA 技术,并详细描述了使用呼吸导航门控来成像冠状动脉的特殊脉冲序列。文章最后解释了相位对比成像技术背后的原理,该技术生成的图像代表 MR 信号的相位而不是幅度。展示了如何通过设计产生与速度成正比的相对相位变化的梯度波形来使用该原理生成速度图。讨论了速度编码范围的选择和使用该技术的关键陷阱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/9bf31dbdc6d4/1532-429X-14-66-36.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/9e726cdc4f21/1532-429X-14-66-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/063bb8823f11/1532-429X-14-66-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/bc94b66e70c2/1532-429X-14-66-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/6cb6c902b2c4/1532-429X-14-66-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/49f9da933e92/1532-429X-14-66-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/3f97296f2b13/1532-429X-14-66-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/60a4272ad64a/1532-429X-14-66-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/a751c41b157e/1532-429X-14-66-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/e92f788fab11/1532-429X-14-66-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/f0cedf14863e/1532-429X-14-66-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/f95672fb051e/1532-429X-14-66-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/e8f99a3c7e54/1532-429X-14-66-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/4e1833338496/1532-429X-14-66-13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/206e5423d0c2/1532-429X-14-66-14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/95f74f67e1a2/1532-429X-14-66-15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/ce820f7da1dc/1532-429X-14-66-16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/a8f5a5881c01/1532-429X-14-66-17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/9f4553d2248c/1532-429X-14-66-18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/072e68dbd924/1532-429X-14-66-19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/60d71f573cc3/1532-429X-14-66-20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/f47811a1a817/1532-429X-14-66-21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/1e1dd2d64268/1532-429X-14-66-22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/c2158dd2df3f/1532-429X-14-66-23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/30c1068d4bbf/1532-429X-14-66-24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/139502180871/1532-429X-14-66-25.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/5833c34bc8ca/1532-429X-14-66-26.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/44f778f5770c/1532-429X-14-66-27.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/290b50e96da6/1532-429X-14-66-28.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/677193e6ab49/1532-429X-14-66-29.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/67cd2c87e9e8/1532-429X-14-66-30.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/2926e847cdd7/1532-429X-14-66-31.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/2a784f511cb6/1532-429X-14-66-32.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/c8f6267cf501/1532-429X-14-66-33.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/3b27ddc862c4/1532-429X-14-66-34.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/f935d19ded86/1532-429X-14-66-35.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/9bf31dbdc6d4/1532-429X-14-66-36.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/9e726cdc4f21/1532-429X-14-66-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/063bb8823f11/1532-429X-14-66-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/bc94b66e70c2/1532-429X-14-66-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/6cb6c902b2c4/1532-429X-14-66-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/49f9da933e92/1532-429X-14-66-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/3f97296f2b13/1532-429X-14-66-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/60a4272ad64a/1532-429X-14-66-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/a751c41b157e/1532-429X-14-66-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/e92f788fab11/1532-429X-14-66-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/f0cedf14863e/1532-429X-14-66-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/f95672fb051e/1532-429X-14-66-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/e8f99a3c7e54/1532-429X-14-66-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/4e1833338496/1532-429X-14-66-13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/206e5423d0c2/1532-429X-14-66-14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/95f74f67e1a2/1532-429X-14-66-15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/ce820f7da1dc/1532-429X-14-66-16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/a8f5a5881c01/1532-429X-14-66-17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/9f4553d2248c/1532-429X-14-66-18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/072e68dbd924/1532-429X-14-66-19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/60d71f573cc3/1532-429X-14-66-20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/f47811a1a817/1532-429X-14-66-21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/1e1dd2d64268/1532-429X-14-66-22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/c2158dd2df3f/1532-429X-14-66-23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/30c1068d4bbf/1532-429X-14-66-24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/139502180871/1532-429X-14-66-25.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/5833c34bc8ca/1532-429X-14-66-26.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/44f778f5770c/1532-429X-14-66-27.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/290b50e96da6/1532-429X-14-66-28.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/677193e6ab49/1532-429X-14-66-29.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/67cd2c87e9e8/1532-429X-14-66-30.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/2926e847cdd7/1532-429X-14-66-31.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/2a784f511cb6/1532-429X-14-66-32.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/c8f6267cf501/1532-429X-14-66-33.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/3b27ddc862c4/1532-429X-14-66-34.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/f935d19ded86/1532-429X-14-66-35.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3438/3533879/9bf31dbdc6d4/1532-429X-14-66-36.jpg

相似文献

1
Cardiovascular magnetic resonance physics for clinicians: Part II.临床心血管磁共振物理:第二部分。
J Cardiovasc Magn Reson. 2012 Sep 20;14(1):66. doi: 10.1186/1532-429X-14-66.
2
Cardiovascular magnetic resonance physics for clinicians: part I.临床心血管磁共振物理:第一部分。
J Cardiovasc Magn Reson. 2010 Nov 30;12(1):71. doi: 10.1186/1532-429X-12-71.
3
Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T.1.5特斯拉下皮下植入式心脏复律除颤器(S-ICD)患者心血管磁共振成像安全性及诊断价值的临床经验
J Cardiovasc Magn Reson. 2020 May 18;22(1):35. doi: 10.1186/s12968-020-00626-y.
4
Cardiovascular magnetic resonance in patients with magnetic resonance conditional pacemaker systems at 1.5 T: influence of pacemaker related artifacts on image quality including first pass perfusion, aortic and mitral valve assessment, flow measurement, short tau inversion recovery and T1-weighted imaging.1.5T磁共振兼容起搏器系统患者的心血管磁共振成像:起搏器相关伪影对图像质量的影响,包括首过灌注、主动脉和二尖瓣评估、血流测量、短反转时间反转恢复序列和T1加权成像。
Int J Cardiovasc Imaging. 2017 Mar;33(3):383-394. doi: 10.1007/s10554-016-1012-z. Epub 2016 Nov 4.
5
Assessment of myocardial perfusion by magnetic resonance imaging.通过磁共振成像评估心肌灌注。
Herz. 1997 Feb;22(1):16-28. doi: 10.1007/BF03044567.
6
Cardiovascular magnetic resonance at 3.0 T: current state of the art.3.0T 心血管磁共振:当前的技术水平。
J Cardiovasc Magn Reson. 2010 Oct 7;12(1):55. doi: 10.1186/1532-429X-12-55.
7
Diagnostic performance of dark-blood T2-weighted CMR for evaluation of acute myocardial injury.心脏磁共振黑血 T2 加权成像在评估急性心肌损伤中的诊断性能。
Invest Radiol. 2013 Jan;48(1):24-31. doi: 10.1097/RLI.0b013e3182718672.
8
A clinical combined gadobutrol bolus and slow infusion protocol enabling angiography, inversion recovery whole heart, and late gadolinium enhancement imaging in a single study.一种临床联合钆布醇团注与缓慢输注方案,可在一项研究中实现血管造影、反转恢复全心成像和钆剂延迟强化成像。
J Cardiovasc Magn Reson. 2016 Oct 5;18(1):66. doi: 10.1186/s12968-016-0285-7.
9
Cardiovascular cine imaging and flow evaluation using Fast Interrupted Steady-State (FISS) magnetic resonance.使用快速中断稳态(FISS)磁共振进行心血管电影成像和流量评估。
J Cardiovasc Magn Reson. 2018 Feb 19;20(1):12. doi: 10.1186/s12968-018-0433-3.
10
Individual component analysis of the multi-parametric cardiovascular magnetic resonance protocol in the CE-MARC trial.CE-MARC试验中多参数心血管磁共振协议的个体成分分析。
J Cardiovasc Magn Reson. 2015 Jul 15;17(1):59. doi: 10.1186/s12968-015-0169-2.

引用本文的文献

1
Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments.心力衰竭中的心脏磁共振成像:诊断与预后评估
J Cardiovasc Dev Dis. 2025 May 23;12(6):200. doi: 10.3390/jcdd12060200.
2
Cardiac Magnetic Resonance Guidance for the Pathogenetic Definition of Cardiomyopathies.心肌病发病机制定义的心脏磁共振引导
Curr Cardiol Rep. 2025 Apr 16;27(1):85. doi: 10.1007/s11886-025-02233-8.
3
Inheritance of Imaging Parameters of Arrhythmic Risk in Mitral Valve Prolapse: A Pedigree Study.二尖瓣脱垂心律失常风险成像参数的遗传研究:一项家系研究。

本文引用的文献

1
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial.心血管磁共振和单光子发射计算机断层扫描诊断冠心病(CE-MARC):一项前瞻性试验。
Lancet. 2012 Feb 4;379(9814):453-60. doi: 10.1016/S0140-6736(11)61335-4. Epub 2011 Dec 22.
2
Non-contrast enhanced MR angiography: established techniques.非增强磁共振血管成像:成熟技术。
J Magn Reson Imaging. 2012 Jan;35(1):1-19. doi: 10.1002/jmri.22789.
3
Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability.
Circ Cardiovasc Imaging. 2025 Jan;18(1):e017051. doi: 10.1161/CIRCIMAGING.124.017051. Epub 2025 Jan 7.
4
Quantification of Replacement Fibrosis in Aortic Stenosis: A Narrative Review on the Utility of Cardiovascular Magnetic Resonance Imaging.主动脉瓣狭窄中替代纤维化的量化:关于心血管磁共振成像效用的叙述性综述
Diagnostics (Basel). 2024 Oct 31;14(21):2435. doi: 10.3390/diagnostics14212435.
5
Look-Locker T1 relaxometry and high-resolution T2 in the evaluation of lung lesions: a single-center prospective study.Look-Locker T1弛豫测量法及高分辨率T2成像在肺病变评估中的应用:一项单中心前瞻性研究
Radiol Bras. 2024 Sep 30;57:e20240033. doi: 10.1590/0100-3984.2024.0033. eCollection 2024 Jan-Dec.
6
Evaluation of Right Ventricular Myocardial Properties Using Systolic Myocardial T1 Mapping.使用收缩期心肌T1映射评估右心室心肌特性
Cureus. 2024 Aug 26;16(8):e67797. doi: 10.7759/cureus.67797. eCollection 2024 Aug.
7
Manganese-Loaded Liposomes: An In Vitro Study for Possible Diagnostic Application.载锰脂质体:一种可能用于诊断应用的体外研究。
Molecules. 2024 Jul 20;29(14):3407. doi: 10.3390/molecules29143407.
8
Cardiovascular magnetic resonance imaging for sequential assessment of cardiac fibrosis in mice: technical advancements and reverse translation.心血管磁共振成像用于小鼠心脏纤维化的序贯评估:技术进展和反向翻译。
Am J Physiol Heart Circ Physiol. 2024 Jan 1;326(1):H1-H24. doi: 10.1152/ajpheart.00437.2023. Epub 2023 Nov 3.
9
Safety of Stress Cardiac Magnetic Resonance in Patients With Moderate to Severe Aortic Valve Stenosis.中重度主动脉瓣狭窄患者行负荷心脏磁共振成像的安全性
J Cardiovasc Imaging. 2023 Jan;31(1):26-38. doi: 10.4250/jcvi.2022.0063.
10
Imaging Methods: Magnetic Resonance Imaging.影像方法:磁共振成像。
Circ Cardiovasc Imaging. 2023 Jan;16(1):e014068. doi: 10.1161/CIRCIMAGING.122.014068. Epub 2023 Jan 17.
MRI 中的示踪动力学建模:评估灌注和毛细血管通透性。
Phys Med Biol. 2012 Jan 21;57(2):R1-33. doi: 10.1088/0031-9155/57/2/R1. Epub 2011 Dec 15.
4
Myocardial tagging by cardiovascular magnetic resonance: evolution of techniques--pulse sequences, analysis algorithms, and applications.心血管磁共振心肌标记:技术的发展——脉冲序列、分析算法和应用。
J Cardiovasc Magn Reson. 2011 Jul 28;13(1):36. doi: 10.1186/1532-429X-13-36.
5
An image-based approach to understanding the physics of MR artifacts.基于图像的方法来理解磁共振伪影的物理现象。
Radiographics. 2011 May-Jun;31(3):849-66. doi: 10.1148/rg.313105115.
6
Magnetic resonance angiography: current status and future directions.磁共振血管造影:现状与未来方向。
J Cardiovasc Magn Reson. 2011 Mar 9;13(1):19. doi: 10.1186/1532-429X-13-19.
7
Cardiovascular magnetic resonance physics for clinicians: part I.临床心血管磁共振物理:第一部分。
J Cardiovasc Magn Reson. 2010 Nov 30;12(1):71. doi: 10.1186/1532-429X-12-71.
8
Quantification of myocardial perfusion by cardiovascular magnetic resonance.心血磁共振心肌灌注定量分析。
J Cardiovasc Magn Reson. 2010 Oct 8;12(1):57. doi: 10.1186/1532-429X-12-57.
9
Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications.心肌梗死患者的心血管磁共振:当前和新兴的应用。
J Am Coll Cardiol. 2009 Dec 29;55(1):1-16. doi: 10.1016/j.jacc.2009.06.059.
10
Myocardial tissue tagging with cardiovascular magnetic resonance.心肌组织磁共振心血管造影技术。
J Cardiovasc Magn Reson. 2009 Dec 21;11(1):55. doi: 10.1186/1532-429X-11-55.